These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7684686)

  • 1. Association of CD22 with the B cell antigen receptor.
    Peaker CJ; Neuberger MS
    Eur J Immunol; 1993 Jun; 23(6):1358-63. PubMed ID: 7684686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B cell antigen receptor-mediated apoptosis. Importance of accessory molecules CD19 and CD22, and of surface IgM cross-linking.
    Chaouchi N; Vazquez A; Galanaud P; Leprince C
    J Immunol; 1995 Apr; 154(7):3096-104. PubMed ID: 7534787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphotyrosine-dependent association between CD22 and protein tyrosine phosphatase 1C.
    Campbell MA; Klinman NR
    Eur J Immunol; 1995 Jun; 25(6):1573-9. PubMed ID: 7542197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SLP-76 is recruited to CD22 and dephosphorylated by SHP-1, thereby regulating B cell receptor-induced c-Jun N-terminal kinase activation.
    Mizuno K; Tagawa Y; Watanabe N; Ogimoto M; Yakura H
    Eur J Immunol; 2005 Feb; 35(2):644-54. PubMed ID: 15668918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A distinct signaling pathway used by the IgG-containing B cell antigen receptor.
    Wakabayashi C; Adachi T; Wienands J; Tsubata T
    Science; 2002 Dec; 298(5602):2392-5. PubMed ID: 12493916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular CD22 rapidly moves to the cell surface in a tyrosine kinase-dependent manner following antigen receptor stimulation.
    Sherbina NV; Linsley PS; Myrdal S; Grosmaire LS; Ledbetter JA; Schieven GL
    J Immunol; 1996 Nov; 157(10):4390-8. PubMed ID: 8906814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling.
    Tedder TF; Tuscano J; Sato S; Kehrl JH
    Annu Rev Immunol; 1997; 15():481-504. PubMed ID: 9143697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD22 associates with the human surface IgM-B-cell antigen receptor complex.
    Leprince C; Draves KE; Geahlen RL; Ledbetter JA; Clark EA
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3236-40. PubMed ID: 8475064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD22 negatively and positively regulates signal transduction through the B lymphocyte antigen receptor.
    Sato S; Tuscano JM; Inaoki M; Tedder TF
    Semin Immunol; 1998 Aug; 10(4):287-97. PubMed ID: 9695185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The B-cell antigen CD22 mediates monocyte and erythrocyte adhesion.
    Stamenkovic I; Seed B
    Nature; 1990 May; 345(6270):74-7. PubMed ID: 1691828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD22 attenuates calcium signaling by potentiating plasma membrane calcium-ATPase activity.
    Chen J; McLean PA; Neel BG; Okunade G; Shull GE; Wortis HH
    Nat Immunol; 2004 Jun; 5(6):651-7. PubMed ID: 15133509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B cell antigen receptor-evoked calcium influx is enhanced in CD22-deficient B cell lines.
    Nadler MJ; McLean PA; Neel BG; Wortis HH
    J Immunol; 1997 Nov; 159(9):4233-43. PubMed ID: 9379018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of CD22 and other inhibitory co-receptors in B-cell activation.
    Nitschke L
    Curr Opin Immunol; 2005 Jun; 17(3):290-7. PubMed ID: 15886119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The internalization of the IgG2a antigen receptor does not require the association with Ig-alpha and Ig-beta but the activation of protein tyrosine kinases does.
    Weiser P; Riesterer C; Reth M
    Eur J Immunol; 1994 Mar; 24(3):665-71. PubMed ID: 8125135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential signaling through the Ig-alpha and Ig-beta components of the B cell antigen receptor.
    Kim KM; Alber G; Weiser P; Reth M
    Eur J Immunol; 1993 Apr; 23(4):911-6. PubMed ID: 7681402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus.
    Lajaunias F; Ida A; Kikuchi S; Fossati-Jimack L; Martinez-Soria E; Moll T; Law CL; Izui S
    Arthritis Rheum; 2003 Jun; 48(6):1612-21. PubMed ID: 12794829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epratuzumab, a humanized monoclonal antibody targeting CD22: characterization of in vitro properties.
    Carnahan J; Wang P; Kendall R; Chen C; Hu S; Boone T; Juan T; Talvenheimo J; Montestruque S; Sun J; Elliott G; Thomas J; Ferbas J; Kern B; Briddell R; Leonard JP; Cesano A
    Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3982S-90S. PubMed ID: 14506197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CD19 complex of B lymphocytes. Activation of phospholipase C by a protein tyrosine kinase-dependent pathway that can be enhanced by the membrane IgM complex.
    Carter RH; Tuveson DA; Park DJ; Rhee SG; Fearon DT
    J Immunol; 1991 Dec; 147(11):3663-71. PubMed ID: 1719083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the expression and gene promoter of CD22 in murine B cells.
    Andersson KB; Draves KE; Magaletti DM; Fujioka S; Holmes KL; Law CL; Clark EA
    Eur J Immunol; 1996 Dec; 26(12):3170-8. PubMed ID: 8977319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive endocytosis and degradation of CD22 by human B cells.
    Shan D; Press OW
    J Immunol; 1995 May; 154(9):4466-75. PubMed ID: 7722303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.